Last €17.75 EUR
Change Today +0.083 / 0.47%
Volume 0.0
3M4 On Other Exchanges
As of 9:49 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

masimo corporation (3M4) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/23/14 - €23.31
52 Week Low
05/9/14 - €15.83
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MASIMO CORPORATION (3M4)

masimo corporation (3M4) Related Bloomberg News

View More Bloomberg News

masimo corporation (3M4) Related Businessweek News

No Related Businessweek News Found

masimo corporation (3M4) Details

Masimo Corporation, a medical technology company, develops, manufactures, and markets various noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology (SET), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; and Masimo rainbow SET products that monitor multiple blood measurements, including oxygen content, carboxyhemoglobin, methemoglobin, hemoglobin, pleth variability index, respiration rate, Halo Index, and In Vivo Adjustment. It develops, manufactures, and markets a family of patient monitoring solutions comprising monitors, circuit boards, sensors, and cables; Root, a patient monitoring and connectivity platform; Masimo Patient SafetyNet, a remote monitoring and clinician notification solution; and various software products. The company also provides line filters, cannulas, and mainstream adapters; and wafer epitaxy, foundry, and device fabrication services to biomedical, telecommunications, consumer products, and other markets, as well as develops and manufactures ultra-compact mainstream and sidestream capnography, and gas monitoring technologies. Masimo Corporation sells its products to hospitals, emergency medical response organizations, physician offices, veterinarians, long term care facilities, consumers, and alternate care market through its direct sales force and distributors, as well as to original equipment manufacturer partners. The company was founded in 1989 and is headquartered in Irvine, California.

3,139 Employees
Last Reported Date: 02/14/14
Founded in 1989

masimo corporation (3M4) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $712.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $334.4K
President of Worldwide Oem Business & Corpora...
Total Annual Compensation: $335.7K
President of Worldwide Sales & Marketing and ...
Total Annual Compensation: $332.4K
Chief Information Officer
Total Annual Compensation: $329.2K
Compensation as of Fiscal Year 2013.

masimo corporation (3M4) Key Developments

Masimo Corporation Announces Executive Changes

On June 27, 2014, Masimo Corporation appointed Anand Sampath as its Chief Operating Officer responsible for the Engineering, Manufacturing, Purchasing, Regulatory and Quality organizations. Mr. Sampath has served as the Executive Vice President, Engineering of Masimo since March 2007. He is an inventor on more than four patents relating to patient monitoring, wireless networks and communications. In connection with the appointment of Anand Sampath as Chief Operating Officer, effective June 27, 2014, Yongsam Lee will no longer be responsible for Manufacturing, Purchasing, Quality, and Regulatory Affairs but will continue to be responsible for Information Technology and Facilities organizations, continuing to serve as Chief Information Officer.

Masimo Announces FDA 510(k) Clearance of the Root Patient Monitoring and Connectivity Platform

Masimo announced FDA 510(k) clearance of the Root patient monitoring and connectivity platform that is destined to transform patient care throughout the hospital. High-impact innovations in Root that are now available in the U.S. include: //st Iris - Built-in connectivity gateway through Iris for standalone devices such as IV pumps, ventilators, hospital beds, and other patient monitors MOC-9- Flexible measurement expansion through Masimo Open Connect (MOC-9) with MOC-9 modules from Masimo or third-party measurement by other companies to expand the platform's measurements and capabilities. New MOC-9 modules will require new 510(k) clearances Capnography - ISA(TM) CO(sub)2(/sub) sidestream module featuring fast warm up time and the innovative and cost-effective Nomoline sampling line Wireless functionality - Capable of transmitting information through Bluetooth and Wi-Fi. Masimo's breakthrough rainbow(r) and SET(r) measurements from the Radical-7(r) handheld monitor that docks into Root enable instant interpretation with a 10-inch high visibility, intuitive navigation touchscreen display. In addition, the previously released SedLine brain function monitoring MOC-9 module for Root advances brain function monitoring to improve the care of patients under anesthesia or sedation. Built-in Connectivity Gateway through Iris. Despite medical technology advances, the lack of device communication and integration creates risks to patient safety in hospitals around the world. Without device interoperability, critical patient information can go unnoticed -- leaving busy clinicians in the dark and vulnerable patients in danger. Existing approaches for device interoperability require separate hardware, software, and/or network infrastructure, which can clutter the patient room, increase complexity, burden IT management, and increase costs.To address these challenges, each Root can be used as a connectivity gateway to connect multiple standalone devices -- such as IV pumps, ventilators, hospital beds, and other patient monitors -- when used as part of the optional Iris connectivity package in Masimo Patient SafetyNet. Iris allows standalone device information to be remotely viewed with Patient SafetyNet, transmitted through notification systems or sent to electronic health record (EHR) systems to facilitate better patient care. Iris connectivity enables standalone devices to leveage existing network infrastructure and reduce costs while enhancing clinical workflows and decision support to improve patient safety, whether the clinician is at the bedside, down the hall, or across the globe. ISA Capnography MOC-9 Module: The ISA CO(sub)2(/sub) module for Root provides ETCO(sub)2(/sub) and respiratory rate measurements with crisp waveforms and fast warm up time. In addition, customers can use the Nomoline 'No Moisture' fluid protection sample line, which is specially designed for low-flow applications and excellent response time -- making gas measurement possible even at high respiratory rates. Nomoline supports single-patient use in high humidity environments or multi-patient use in lower-humidity environments to reduce disposable costs, and can be used for all types of patients from infants to adults. MOC-9: Designed for Third-Party Development of Expanded Measurements: Root is also designed to allow other companies to expand the platform's measurements with their own measurements through MOC-9 by following Masimo's established development and validation process. Market barriers and development costs often keep small, innovative companies from delivering their products to clinicians and patients who need them most. With Root's accessible patient monitoring platform, Masimo is offering an open invitation to other companies to develop and commercialize their innovations through Masimo's ever-expanding customer base.

Masimo Corporation(NasdaqGS:MASI) added to S&P SmallCap 600 Index

Masimo Corporation(NasdaqGS:MASI) added to S&P SmallCap 600 Index


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3M4:GR €17.75 EUR +0.083

3M4 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chemed Corp $97.21 USD +0.42
CONMED Corp $38.25 USD -4.47
Hutchinson Technology Inc $2.10 USD 0.00
Integra LifeSciences Holdings Corp $47.66 USD -0.08
LiDCO Group PLC 17.25 GBp 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 3M4 Industry Range
Price/Earnings 21.5x
Price/Sales 2.5x
Price/Book 3.9x
Price/Cash Flow 21.2x
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MASIMO CORPORATION, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at